Clinical Investigational Agents Consisting of Recombinant DNA or Infectious Agents


This Health Care Systems policy details the requirements for all investigational gene therapy agents or infectious agents that will be introduced into human subjects as part of a research protocol.

View Policy and Procedure 

About this Policy

Program: Institutional Biosafety Committee
Type: IBC Policies